Granuloma annulare: a case treated with infliximab successfully

G Ital Dermatol Venereol. 2017 Apr;152(2):193-195. doi: 10.23736/S0392-0488.16.05320-7.

Authors

Alessandro Giunta¹, Andrea Chiricozzi², Maria V Cannizzaro³, Annunziata Dattola¹, Manuela Ruzzetti¹, Steven P Nisticò¹, Sergio Chimenti¹

Affiliations

¹ Section of Dermatology, Academic Department of Systems Medicine, School of Medicine, Tor Vergata University Hospital, Rome, Italy.
² Dermatology Department, University of Pisa, Pisa, Italy.
³ Section of Dermatology, Academic Department of Systems Medicine, School of Medicine, Tor Vergata University Hospital, Rome, Italy - mariavittoria.cannizzaro@gmail.com.

PMID: 28166622
DOI: 10.23736/S0392-0488.16.05320-7

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Dermatologic Agents / pharmacology
Dermatologic Agents / therapeutic use*
Granuloma Annulare / drug therapy*
Granuloma Annulare / pathology
Humans
Infliximab / pharmacology
Infliximab / therapeutic use*
Male
Treatment Outcome
Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

Dermatologic Agents
Tumor Necrosis Factor-alpha
Infliximab